Patents by Inventor Soo Ho Ban

Soo Ho Ban has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL PYRAZOLE DERIVATIVE
    Publication number: 20230067461
    Abstract: The present invention provides a novel pyrazole derivative compound represented by Chemical formula I or a salt thereof, and a pharmaceutical composition comprising the same.
    Type: Application
    Filed: January 12, 2021
    Publication date: March 2, 2023
    Inventors: Soo Jin LEE, Sung Hwan MOON, Soo Ho BAN, Eun Sil LEE, Eun Jung SHIN, Yoo-Kyung GOH, Sung Chan LEE, Hyun Kyung KU
  • Indirubin-3?-oxime derivatives as potent cyclin dependent kinase inhibitors
    Patent number: 8859783
    Abstract: The present invention relates to an indirubin-3?-oxime derivative as potent cyclin dependent kinase inhibitor with anti-cancer activity. More particularly, this invention relates to an indirubin-3?-oxime derivative as potent cyclin dependent kinase inhibitor having excellent anti-cancer activity against human lung cancer cell, human fibro sarcoma cell, human colon cancer cell, human leukemia cell, human stomach cancer cell, human nasopharyngeal cancer cell and/or human breast cancer cell.
    Type: Grant
    Filed: January 28, 2011
    Date of Patent: October 14, 2014
    Assignee: Anygen Co., Ltd.
    Inventors: Yong-Chul Kim, Jae-Il Kim, Soo-Ho Ban, Soon-Young Jeong, Soo-Jeong Choi, Jung-Eun Lee
  • INDIRUBIN-3'-OXIME DERIVATIVES AS POTENT CYCLIN DEPENDENT KINASE INHIBITORS
    Publication number: 20120295948
    Abstract: The present invention relates to an indirubin-3?-oxime derivative as potent cyclin dependent kinase inhibitor with anti-cancer activity. More particularly, this invention relates to an indirubin-3?-oxime derivative as potent cyclin dependent kinase inhibitor having excellent anti-cancer activity against human lung cancer cell, human fibro sarcoma cell, human colon cancer cell, human leukemia cell, human stomach cancer cell, human nasopharyngeal cancer cell and/or human breast cancer cell.
    Type: Application
    Filed: January 28, 2011
    Publication date: November 22, 2012
    Applicant: ANYGEN CO., LTD.
    Inventors: Yong-Chul Kim, Jae-II Kim, Soo-Ho Ban, Soon-Young Jeong, Soo-Jeong Choi, Jung-Eun Lee
  • Cyclic lipid derivatives as potent PAF antagonists
    Patent number: 5700817
    Abstract: The present invention describes novel cyclic diol derivatives represented by formula I and II: ##STR1## in which Y represents O, S, SO, SO.sub.2, (CH.sub.2).sub.m wherein m is zero or an integer of 1 to 5, or NR.sup.2 group wherein R.sup.a is hydrogen, lower alkyl, lower alkoxycarbonyl, aryl, arylalkyl or acyl;R.sup.1 represents an alkyl or alkylcarbamoyl group;R.sup.2 represents a group having formula T--(CH.sub.2).sub.n --V (X.sup.-)q, wherein T refers to a simple covalent bond, a CO, PO.sub.3.sup.-, C(O)O, or CONR.sup.b group wherein R.sup.b is hydrogen, lower alkyl or acyl;n refers to an integer of from 1 to 10;V represents either (i) the group indicated by formula --.sup.+ NR.sup.5 R.sup.6 R.sup.7 wherein R.sup.5, R.sup.6 and R.sup.7 stands for identical or different lower alkyl group, or two or three of R.sup.5, R.sup.6 and R.sup.7 taken together with the adjacent nitrogen form heterocyclic ammonio group, or (ii) the group indicated by the formula ##STR2## wherein R.sup.
    Type: Grant
    Filed: November 6, 1995
    Date of Patent: December 23, 1997
    Assignees: Pohang Iron & Steel Co., Ltd., Research Institute of Industrial Science & Technology
    Inventors: Soon Hyung Woo, Sung Kee Chung, Soo Ho Ban, Byoung Eog Kim, Si Hwan Kim